Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Women may start at the lower end of dosing ranges and titrate based on response, as some research suggests women may be more sensitive to certain peptides
10.1016/j.nbd.2009.02.019 Neurobiol Dis
Adherence and injection technique, which is assessed at the beginning of treatment
Additionally, Shanghai Domiruis GCGR agonist,Glucagon (Domirui Biotechnology), is in Phase 1 clinical trials
US$ 20.30
US$ 26.48
US$ 25.78
US$ 29.52
US$ 23.75
US$ 28.70
